Rafarma Pharmaceuticals (Laskavy Patent) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Rafarma Pharmaceuticals (Laskavy Patent) General Information

Description

A medicinal patent right in the United States. The assets offer the company access to several new technologies including the new generation immune modulator XR.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Acquirer
Rafarma Pharmaceuticals
Primary Office
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Rafarma Pharmaceuticals (Laskavy Patent) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Rafarma Pharmaceuticals (Laskavy Patent)‘s full profile, request access.

Request a free trial